ABA Editorial · Aug 18, 2025 · 14 min read
Medical supply chain reliability is the foundation of any functioning health system. African medical supply chains face fragmentation, counterfeiting concerns, inconsistent cold chain infrastructure, and last-mile delivery gaps that undermine clinical effectiveness. Operators including Zipline have used drone technology to address specific gaps. This report maps the supply chain landscape and the operators working to close the gaps.
Medical supply chain reliability is the foundation that every other component of a functioning health system depends on. A hospital cannot provide care without reliable supply of pharmaceuticals, diagnostic reagents, consumables, and equipment. A vaccination program cannot meet its targets without reliable cold chain infrastructure to keep vaccines at specified temperatures from manufacture to injection. A laboratory cannot deliver accurate diagnoses without reliable reagent supply and equipment calibration. African medical supply chains face structural challenges across each of these dimensions: fragmented distribution networks, counterfeiting concerns, inconsistent cold chain infrastructure, and last-mile delivery gaps that leave rural and remote facilities chronically under-supplied. This report maps the medical supply chain landscape, the operators working to close specific gaps, and the structural conditions that determine whether improvements can scale.
Cold chain reliability is the most specific and measurable medical supply chain challenge in African contexts. Vaccines, certain diagnostic reagents, and a growing category of temperature-sensitive therapeutics must be kept within narrow temperature ranges from manufacture through administration. A vaccine exposed to excessive heat (or in some cases excessive cold) loses potency and may fail to provide protection even if the physical vial reaches the patient. Africa's tropical climate, unreliable electricity infrastructure, and long distribution distances between central storage and peripheral facilities create specific challenges for cold chain maintenance.
Solar-powered cold storage has become an important element of the response. Solar refrigeration units at health facilities allow vaccine storage independent of unreliable grid electricity. Similar technology deployed at district-level storage sites supports the intermediate cold chain between central warehouses and peripheral clinics. The Mission 300 continental electrification initiative is relevant to cold chain reliability because it addresses the broader electricity access problem that undermines healthcare infrastructure alongside its more visible impacts on households and businesses.
Zipline, the drone logistics company founded in California with substantial African operations, has built the most visible response to African medical last-mile delivery challenges. The company operates fixed-wing drones that deliver blood products, vaccines, and medicines from distribution centers to remote health facilities across Rwanda, Ghana, and several other African countries. The Rwandan national blood supply has been delivered primarily through Zipline operations for several years, and the Ghanaian partnership has extended similar service to communities across the country.
The Zipline model works for specific use cases: lightweight, time-critical medical products where the cost premium of drone delivery is justified by the value of rapid delivery or the impossibility of road-based alternatives. It does not work for bulk commodity medicines where weight and volume make drone economics uncompetitive. Within its applicable scope, Zipline has demonstrated that drone logistics can address last-mile gaps that conventional distribution cannot reach, and the model has attracted government partnerships that provide stable operating revenue.
Counterfeit and substandard medicines remain one of the most serious structural problems in African medical supply chains. Studies from the World Health Organization and other sources have documented that significant percentages of medicines in some African markets are counterfeit or substandard, with particular concentration in antimalarial, antibiotic, and cardiovascular drug categories. The consequences include treatment failure, development of drug resistance (particularly relevant for antimalarials and antibiotics), and direct patient harm.
The structural response requires several interventions working together. Regulatory enforcement at borders and in distribution channels must detect and remove counterfeit products. Supply chain verification systems must allow downstream actors (pharmacies, hospitals, patients) to verify the authenticity of products they handle. Manufacturer serialization (adding unique identifiers to individual packages) supports verification but requires investment that not all manufacturers have made. And patient education must help consumers distinguish between trusted sources and informal channels where counterfeit risk is highest.
Most African medical supply chains route a significant share of pharmaceutical and diagnostic supplies through government procurement systems. National central medical stores purchase products in bulk and distribute them to public health facilities across the country. The efficiency of these systems varies dramatically across countries. Some national procurement systems operate with reasonable transparency and reliable delivery. Others have been subject to delays, stockouts, and occasionally corruption concerns that undermine clinical operations.
International donor programs including the Global Fund to Fight AIDS, Tuberculosis, and Malaria, Gavi the Vaccine Alliance, and PEPFAR have historically supplied significant portions of African essential medicines for specific disease categories, operating through parallel supply chains that supplement national systems. These donor-financed supply chains have often been more reliable than national systems for the specific products they cover, but they create a fragmented supply environment where different products reach facilities through different channels with different reliability characteristics.
A growing category of operators has built software systems for medical supply chain management, targeting the visibility and coordination gaps that plague existing operations. These systems provide inventory tracking across facility levels, stockout prediction, automated reordering, and reporting that gives public health officials and supply chain managers real-time visibility into what is happening across their networks. The technology is not inherently African; similar systems operate in high-income countries for commercial pharmaceutical distribution. The African application requires adapting the technology to local conditions including intermittent connectivity, varying workforce digital literacy, and the specific supply chain architectures that different African countries operate.
Three indicators will shape African medical supply chain development. First, whether Zipline and comparable drone delivery models extend to additional African countries and product categories, validating the operational model beyond its current footprint. Second, whether Mission 300 electrification progress translates into improved cold chain reliability at peripheral health facilities, unlocking broader delivery of temperature-sensitive products. Third, whether African Medicines Agency operational progress reduces regulatory fragmentation that currently complicates cross-border supply chain planning. Medical supply chains are the infrastructure layer on which every other healthcare intervention depends, and their improvement is one of the highest-leverage interventions available in African health systems.